FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/087028 [Registered on: 16/05/2025] Trial Registered Prospectively
Last Modified On: 14/05/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   The effect of isobaric Ropivacaine and isobaric Levobupivacaine with addition of Fentanyl in spinal anaesthesia for postoperative pain relief in patients posted for lower abdominal surgeries . 
Scientific Title of Study   To compare the efficacy of isobaric Ropivacaine 0.75 percent with isobaric Levobupivacaine 0.5 percent in spinal anaesthesia with inj Fentanyl as an adjuvant in patients posted for lower abdominal surgeries .  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Monika Varun Mittal  
Designation  Assistant professor  
Affiliation  Smt Kashibai Navale Medical College And Hospital 
Address  Third floor ,Department of anaesthesia ,smt kashibai navale medical college and general hospital .Narhe,Pune

Pune
MAHARASHTRA
411041
India 
Phone  9158224311  
Fax    
Email  monikatyagi1590@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Monika Varun Mittal  
Designation  Assistant professor  
Affiliation  Smt Kashibai Navale Medical College And Hospital 
Address  Third floor ,Department of anaesthesia ,smt kashibai navale medical college and general hospital .Narhe,Pune

Pune
MAHARASHTRA
411041
India 
Phone  9158224311  
Fax    
Email  monikatyagi1590@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Monika Varun Mittal  
Designation  Assistant professor  
Affiliation  Smt Kashibai Navale Medical College And Hospital 
Address  Third floor ,Department of anaesthesia ,smt kashibai navale medical college and general hospital .Narhe,Pune

Pune
MAHARASHTRA
411041
India 
Phone  9158224311  
Fax    
Email  monikatyagi1590@gmail.com  
 
Source of Monetary or Material Support  
nil 
 
Primary Sponsor  
Name  Dr Monika Varun Mittal  
Address  Third floor ,Department of anaesthesia ,smt kashibai navale medical college and general hospital .Narhe,Pune 411041 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Sumedha Mehta   Department of anaesthesia , smt kashibai navale medical college and general hospital , narhe ,pune, 411041 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Monika Varun Mittal  Smt kashibai navale hospital   Operation theater,Third floor ,Department of anaesthesia ,Smt kashibai navale medical college and general hospital .Narhe,Pune
Pune
MAHARASHTRA 
9158224311

monikatyagi1590@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
smt kashibai navale medical college and general hospital institutional ethical committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K429||Umbilical hernia without obstruction or gangrene, (2) ICD-10 Condition: N433||Hydrocele, unspecified, (3) ICD-10 Condition: N47||Disorders of prepuce, (4) ICD-10 Condition: K37||Unspecified appendicitis, (5) ICD-10 Condition: N35||Urethral stricture, (6) ICD-10 Condition: K419||Unilateral femoral hernia, withoutobstruction or gangrene, (7) ICD-10 Condition: K458||Other specified abdominal hernia without obstruction or gangrene, (8) ICD-10 Condition: N759||Disease of Bartholins gland, unspecified, (9) ICD-10 Condition: N768||Other specified inflammation of vagina and vulva, (10) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Intrathecal isobaric Levobupivacaine  Inj levobupivacaine 0.5 percent isobaric 3ml along with inj Fentanyl 25 micrograms 0.5ml will be given intrathecally to the patients undergoing lower abdominal surgeries. 
Comparator Agent  Intrathecal isobaric Ropivacaine  Inj Ropivacaine 0.75 percent isobaric 3ml along with inj Fentanyl 25 micrograms 0.5ml will be given intrathecally to the patients undergoing lower abdominal surgeries. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1.ASA I &II patients
2.Patients posted for elective lower abdominal surgeries under spinal anaesthesia.
 
 
ExclusionCriteria 
Details  1.Patient refusal
2.Contraindication to subarachnoid block.
3.Central or peripheral neuropathies
4.Patients with bleeding disorders and those on anticoagulant therapy.
5.History of allergy to local anaesthetics.
6.Infection at site of block.
7.Obesity
8.Pregnant women.
9 Patients with psychiatric behaviour
10. History of chronic opioid use  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Comparison of Duration of postoperative Analgesia between two groups isobaric levobupivacaine with fentanyl and isobaric ropivacaine with fentanyl  from the time of administration of study drug intrathecally to the patient complaint of pain postoperatively or VAS more than 3 postoperatively till 24 hours. 
 
Secondary Outcome  
Outcome  TimePoints 
Comparision of hemodynamic stability between two groups isobaric ropivacaine with fentanyl and isobaric levobupivavaine with fentanyl   from the administration of drug in spinal till completion of surgery and postoperative till 24 hours 
Comparision of adverse effects between two groups isobaric ropivacaine with fentanyl and isobaric levobupivavaine with fentanyl  from the administration of drug in spinal till completion of surgery and postoperative till 24 hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   26/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  26/05/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Title of the study project is TO COMPARE THE EFFICACY OF ISOBARIC ROPIVACAINE  AND ISOBARIC LEVOBUPIVACAINE IN SPINAL ANAESTHESIA WITH INJ FENTANYL AS AN ADJUVANT IN PATIENTS POSTED FOR LOWER ABDOMINAL SURGERIES.In our study we want to compare the efficacy of intrathecal isobaric ropivacaine 0.75 percent 3ML with fentanyl 25 mcg 0.5ml  and isobaric levobupivacaine 0.5 percent 3ml with fentanyl 25 mcg 0.5 ml as adjuvant for the quality of anaesthesia and postoperative analgesia in patients undergoing elective lower abdominal surgeries  .Primary objective is to compare the characteristics of blockade and duration of post operative analgesia between two groups.Secondary objectives are Comparison with respect to haemodynamic parameters and Comparison with respect to adverse effects and complications This study will be conducted at Smt Kashibai Navale Medical College and General Hospital Pune. After taking informed written consent, patients aged between 18 to 65 years of either sex will be randomly allocated into two groups using computer generated random number tables as Group RF in which patients will receive Intrathecal isobaric Ropivacaine 0.75 percent 3 ml with inj fentanyl 25mcg 0.5 ml and Group LF will receive Intrathecal hyperbaric Levobupivacaine 0.5 percent 3 ml with inj fentanyl 25mcg 0.5ml.Our hypothesis is that both sensory and motor blockade will be better with levobupivacaine as compared to ropivacaine and adding fentanyl as an adjuvant will increase the duration of postoperative analgesia

 
Close